Overall Fundamental outlook

Business Operations:

Sector: Financial Services
Industry: Insurance - Diversified

Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals, families, children, senior citizens, and persons with pre-existing medical conditions; group health insurance products for employer/employee and non-employer/employee groups, including small-to-medium enterprises; and personal accident and travel insurance products. The company also provides star women care insurance policy that provides surrogacy and oocyte donor covers; and star special care product that covers children diagnosed with autism and for outpatient specialized treatments. In addition, it offers star health assure insurance policy, star cancer care platinum insurance policy, star cardiac care insurance policy – platinum, young star extra protect – add-on cover, antyodaya shramik suraksha yojana, star group domestic travel insurance policy, smart health pro, star domestic travel insurance policy, as well as star group OPD care insurance product. The company offers its products through web aggregators, digital channels, agency channels, corporate agents, brokers, point of sale persons, insurance marketing firms, and other channels. Star Health and Allied Insurance Company was incorporated in 2005 and is based in Chennai, India.

Revenue projections:

Revenue projections for STARHEALTH
Revenue projections for STARHEALTH

Star Health and Allied Insurance Company Limited is projected to experience a revenue decline compared to last year, a development that often leads to investor caution. The drop could negatively impact the company's bottom line, as lower revenues typically signal reduced profitability, prompting more conservative investment strategies.

Financial Ratios:

currentRatio 0.000000
forwardPE 26.535334
debtToEquity 0.000000
earningsGrowth 188.000000
revenueGrowth 0.138000
grossMargins 0.212240
operatingMargins 0.032490
trailingEps 9.480000
forwardEps 21.748360

STARHEALTH's Forward PE ratio is favorable, meaning the stock price aligns well with earnings and isn't overvalued. This allows room for growth, making it an attractive investment for those seeking potential upside while ensuring the stock is not overpriced.
STARHEALTH's positive earnings and revenue growth signal the company's business is on track for further expansion. These strong financial trends suggest that STARHEALTH will continue to grow its operations, driven by increasing profits and revenue.
STARHEALTH's forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights STARHEALTH's potential for increased earnings and a stronger financial performance in the upcoming year.

Price projections:

Price projections for STARHEALTH
Price projections for STARHEALTH

STARHEALTH's price has consistently hovered around the lower limit of price projections. This pattern suggests that the stock may be underperforming relative to expectations, which could lead to concerns among investors.

Insider Transactions:

Insider Transactions for STARHEALTH
Insider Transactions for STARHEALTH


STARHEALTH had 6 buy transactions while market price was at 474.1333312988281 per share.No buy transactions occurred in the period under review.STARHEALTH has experienced more selling activity at current price levels, which could suggest a bearish outlook. If the trend of increased selling continues, it may result in further price declines for the stock.

Recommendation changes over time:

Recommendations trend for STARHEALTH
Recommendations trend for STARHEALTH


Analysts' buy bias toward STARHEALTH suggests the stock is seen as a solid investment, potentially motivating investors to consider it for their portfolios. With this positive outlook, STARHEALTH is likely to be viewed as a secure place to allocate funds, driving further interest in the stock.